A predictive factor for the response to S-1 plus cisplatin in gastric cancer

doi:10.3748/wjg.v16.i36.4575

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3146)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

370

HTML

2303

Figures (1-2)

248

Tables (1-4)

225

Sum=3146

Sep 28, 2010 (publication date) through Jan 26, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 28, 2010; 16(36): 4575-4582
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4575

Open in New Tab Full Size Figure Download Figure

Figure 1 Metabolic pathway of 5-fluorouracil. DPD: Dihydropyrimidine dehydrogenase; TS: Thymidylate synthase; TK: Thymidine kinase; TP: Thymidine phosphorylase; UP: Uridine phosphorylase; OPRT: Orotate phosphoribosyl transferase; UK: Uridine kinase.

Open in New Tab Full Size Figure Download Figure

Figure 2 Changes in the protein expression level of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase. 1st evaluation: Protein expression and response at the first S-1/CDDP chemotherapy; 2nd evaluation: Protein expression and response at the first progression after response or the latest S-1/CDDP chemotherapy. TS: Thymidylate synthase; DPD: Dihydropyrimidine dehydrogenase; OPRT: Orotate phosphoribosyl transferase.

Citation: Miyazaki I, Kawai T, Harada Y, Moriyasu F. A predictive factor for the response to S-1 plus cisplatin in gastric cancer. World J Gastroenterol 2010; 16(36): 4575-4582
URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4575.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4575